A targeted screening program for latent tuberculosis infection among hematopoietic cell transplant recipients

Article

Abstract: Background. US hematopoietic cell transplantation (HCT) recipients have a low prevalence of latent t

Palabras claves:

Cáncer, Hematopoietic cell transplant, QuantiFERON, screening, Tuberculosis

Autores:

Andrea Sosa-Moreno, Edelstein R., Holmberg L., Lind M.L., Liu C., Narita M., Pergam S.A., Podczervinski S., Spitters C., Swetky M.

Fuentes:

scopus